| Literature DB >> 27560966 |
Kanako Ichikura1,2, Yasuyuki Okumura2, Takashi Takeuchi3.
Abstract
OBJECTIVES: Some patients with deliberate drug poisoning subsequently have an adverse clinical course. The present study aimed to examine whether the type of drugs ingested and psychiatric diagnoses were related to an adverse clinical course.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27560966 PMCID: PMC4999209 DOI: 10.1371/journal.pone.0161996
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram for inclusion in the study.
Characteristics of the study participants.
| Total (N = 676) | ||
|---|---|---|
| Characteristic | n | % |
| Age | ||
| ≤19 years | 38 | 5.6 |
| 20–34 years | 328 | 48.5 |
| 35–49 years | 227 | 33.6 |
| 50–64 years | 47 | 6.9 |
| ≥65 years | 36 | 5.3 |
| Gender | ||
| Men | 156 | 23.1 |
| Women | 520 | 76.9 |
| Living arrangement | ||
| Alone | 179 | 26.5 |
| With family | 494 | 73.1 |
| Unknown | 3 | 0.4 |
| History of psychiatric treatment | 581 | 87.6 |
| Reason for self-harm | ||
| Impulsive | 592 | 87.6 |
| Planned | 52 | 7.7 |
| Hallucination/delusion | 15 | 2.2 |
| Others | 7 | 1.0 |
| Unknown | 10 | 1.5 |
| Suicidal ideation | ||
| With | 403 | 59.9 |
| Without | 188 | 27.9 |
| Unknown | 82 | 12.2 |
| Drugs ingested | ||
| Psychotropic drug | 557 | 82.4 |
| Over-the-counter drug | 103 | 15.2 |
| Other drugs | 16 | 2.4 |
| Alcohol intake with overdose | 468 | 69.2 |
The top 20 substances that led to ICU admission for overdose.
| Total (n = 676) | Incidence (%) | |||
|---|---|---|---|---|
| Substance | n | % | Prolonged ICU stay | Aspiration pneumonitis |
| Total | 676 | 100.0 | 10.2 | 10.7 |
| 1. Flunitrazepam | 178 | 26.3 | 10.1 | 15.7 |
| 2. Etizolam | 121 | 17.9 | 8.3 | 10.7 |
| 3. Brotizolam | 113 | 16.7 | 9.7 | 12.4 |
| 4. Zolpidem | 105 | 15.5 | 8.6 | 11.4 |
| 5. Chlorpromazine-promethazine-phenobarbital | 104 | 15.4 | 20.2 | 28.8 |
| 6. Triazolam | 103 | 15.2 | 10.7 | 13.6 |
| 7. Bromazepam | 91 | 13.5 | 12.1 | 16.5 |
| 8. Alprazolam | 89 | 13.2 | 7.9 | 10.1 |
| 9. Valproate | 82 | 12.1 | 7.3 | 8.5 |
| 10. Nitrazepam | 71 | 10.5 | 9.9 | 16.9 |
| 11. Levomepromazine | 63 | 9.3 | 4.8 | 15.9 |
| 12. Acetaminophen | 61 | 9.0 | 11.5 | 0.0 |
| 13. Paroxetine | 59 | 8.7 | 13.6 | 15.3 |
| 14. Fluvoxamine | 58 | 8.6 | 12.1 | 17.2 |
| 15. Lorazepam | 48 | 7.1 | 8.3 | 16.7 |
| 16. Risperidone | 48 | 7.1 | 4.2 | 4.2 |
| 17. Diazepam | 43 | 6.4 | 7.0 | 11.6 |
| 18. Estazolam | 43 | 6.4 | 14.0 | 18.6 |
| 19. Chlorpromazine | 41 | 6.1 | 14.6 | 17.1 |
| 20. Clonazepam | 41 | 6.1 | 7.3 | 7.3 |
a The denominator was the number of patients who ingested a substance and the numerator was the number of incident cases among the patients.
ICU = intensive care unit
Major classes of overdose.
| Total (n = 676) | Incidence (%) | |||
|---|---|---|---|---|
| Class | n | % | Prolonged ICU stay | Aspiration pneumonitis |
| Total | 676 | 10.2 | 10.7 | |
| 1. Benzodiazepine receptor agonists | 537 | 79.4 | 9.7 | 11.5 |
| 2. New-generation antidepressants | 169 | 25.0 | 9.5 | 11.8 |
| 3. Barbiturates/non-barbiturates | 155 | 22.9 | 17.4 | 23.9 |
| 4. First-generation antipsychotics | 148 | 21.9 | 10.1 | 13.5 |
| 5. Pain killers | 135 | 20.0 | 7.4 | 3.7 |
| 6. Second-generation antipsychotics | 131 | 19.4 | 9.2 | 13.0 |
| 7. Mood stabilizers | 117 | 17.3 | 7.7 | 9.4 |
| 8. Other classes | 116 | 17.2 | 5.2 | 3.4 |
| 9. Drugs affecting the gut | 77 | 11.4 | 7.8 | 11.7 |
| 10. Tricyclic antidepressants | 72 | 10.7 | 9.7 | 18.1 |
| 11. Antiparkinson drugs | 71 | 10.5 | 14.1 | 22.5 |
| 12. Other antidepressants | 63 | 9.3 | 12.7 | 11.1 |
| 13. Antiallergic drugs | 31 | 4.6 | 16.1 | 3.2 |
| 14. Other sedatives and hypnotics | 32 | 4.7 | 15.6 | 6.3 |
| 15. Cardiovascular drugs | 19 | 2.8 | 15.8 | 5.3 |
| 16. Anticonvulsants | 4 | 0.6 | 25.0 | 0.0 |
a The denominator was the number of patients who ingested a substance and the numerator was the number of incident cases among the patients.
ICU = intensive care unit
Psychiatric diagnoses.
| Total (n = 676) | Incidence (%) | |||
|---|---|---|---|---|
| Diagnosis | n | % | Prolonged ICU stay | Aspiration pneumonitis |
| Total | 676 | 10.2 | 10.7 | |
| 1. Major depressive disorders | 174 | 25.7 | 13.8 | 10.3 |
| 2. Adjustment disorders | 157 | 23.2 | 7.0 | 7.0 |
| 3. Borderline personality disorders | 148 | 21.9 | 8.8 | 12.2 |
| 4. Schizophrenia | 72 | 10.7 | 16.7 | 18.1 |
| 5. Bipolar disorders | 59 | 8.7 | 6.8 | 13.6 |
| 6. Anxiety disorders | 56 | 8.3 | 5.4 | 10.7 |
| 7. Other personality disorders | 29 | 4.3 | 27.6 | 6.9 |
| 8. No psychiatric diagnoses | 17 | 2.5 | 11.8 | 0.0 |
| 9. Substance use disorders | 15 | 2.2 | 13.3 | 13.3 |
| 10. Alcohol use disorders | 13 | 1.9 | 15.4 | 30.8 |
| 11. Eating disorders | 9 | 1.3 | 0.0 | 11.1 |
| 12. Dementia | 6 | 0.9 | 16.7 | 16.7 |
a The denominator was the number of patients who have a psychiatric diagnosis and the numerator was the number of incident cases among the patients.
ICU = intensive care unit
Risk factors for adverse clinical course.
| Incidence (%) | Odds ratio (95% confidence interval) | ||||
|---|---|---|---|---|---|
| Characteristic | n | Prolonged ICU stay | Aspiration pneumonitis | Prolonged ICU stay | Aspiration pneumonitis |
| Sedative-hypnotics | |||||
| Only benzodiazepine receptor agonists/others | 426 | 8.2 | 7.7 | ref | ref |
| Barbiturates/non-barbiturates | 155 | 17.4 | 23.9 | 2.97 (1.60, 5.55) | 3.83 (2.18, 6.79) |
| No sedative-hypnotics | 95 | 7.4 | 2.1 | 1.03 (0.36, 2.62) | 0.35 (0.05, 1.30) |
| Antidepressants | |||||
| Only new-generation antidepressants/others | 168 | 8.3 | 10.7 | ref | ref |
| Tricyclic antidepressants | 72 | 9.7 | 18.1 | 0.85 (0.27, 2.42) | 2.25 (0.93, 5.38) |
| No antidepressants | 436 | 11.0 | 9.4 | 1.18 (0.58, 2.53) | 0.85 (0.44, 1.71) |
| Antipsychotics | |||||
| Only second-generation antipsychotics | 92 | 9.8 | 12.0 | ref | ref |
| First-generation antipsychotics | 148 | 10.1 | 13.5 | 0.78 (0.30, 2.08) | 1.02 (0.43, 2.53) |
| No antipsychotics | 436 | 10.3 | 9.4 | 0.98 (0.43, 2.46) | 1.12 (0.50, 2.66) |
| Other classes (ref = without each drug class) | |||||
| Mood stabilizers | 117 | 7.7 | 9.4 | 0.75 (0.30, 1.69) | 0.56 (0.24, 1.21) |
| Antiparkinson drugs | 71 | 14.1 | 22.5 | 1.76 (0.70, 4.17) | 2.77 (1.26, 5.96) |
| Pain killers | 135 | 7.4 | 3.7 | 1.27 (0.54, 2.83) | 0.59 (0.19, 1.53) |
| Antiallergy drugs | 31 | 16.1 | 3.2 | 2.67 (0.78, 7.85) | 0.28 (0.01, 1.61) |
| Cardiovascular drugs | 19 | 15.8 | 5.3 | 0.97 (0.19, 3.74) | 0.14 (0.01, 0.91) |
| Drugs affecting the gut | 77 | 7.8 | 11.7 | 0.59 (0.20, 1.49) | 1.10 (0.44, 2.53) |
| Other | 120 | 5.8 | 3.3 | 0.59 (0.22, 1.34) | 0.23 (0.06, 0.64) |
| Major diagnosis | |||||
| Adjustment disorders | 156 | 7.1 | 7.1 | ref | ref |
| Bipolar disorders | 59 | 6.8 | 13.6 | 1.37 (0.33, 4.83) | 2.07 (0.65, 6.39) |
| Major depressive disorders | 174 | 13.8 | 10.3 | 1.82 (0.77, 4.51) | 0.87 (0.36, 2.18) |
| Schizophrenia | 72 | 16.7 | 18.1 | 2.65 (0.95, 7.54) | 1.81 (0.68, 4.86) |
| Other | 215 | 8.4 | 10.2 | 0.73 (0.27, 1.99) | 0.70 (0.25, 1.96) |
| Other diagnoses | |||||
| Borderline personality disorders | 148 | 8.8 | 12.2 | 2.87 (1.13, 7.14) | 1.86 (0.79, 4.27) |
| Other personality disorders | 29 | 27.6 | 6.9 | 6.50 (2.15, 19.12) | 0.90 (0.13, 3.79) |
| Anxiety disorders | 56 | 5.4 | 10.7 | 1.18 (0.25, 4.21) | 1.54 (0.46, 4.65) |
| Substance use disorders | 15 | 13.3 | 13.3 | 1.63 (0.21, 7.91) | 0.85 (0.11, 4.26) |
| Alcohol use disorders | 13 | 15.4 | 30.8 | 1.49 (0.17, 8.07) | 5.40 (1.13, 23.01) |
a The denominator was the number of patients who ingested a substance or who have a psychiatric diagnosis and the numerator was the number of incident cases among the patients.
b Adjusted for sex, age, psychiatric diagnoses, drug classes ingested, and alcohol intake.
ICU = intensive care unit; ref = reference group.
* p < 0.05.